Trial intelligence / Profile preview

Monthly subcutaneous C.E.R.A. for hemoglobin maintenance in chronic kidney disease patients on peritoneal dialysis

2008-001747-18Phase 3Completed

Sponsor
Roche
Start
May 2008
Modality
Recombinant Proteins and Enzymes, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Countries
1
01

Overview

Phase 3, single-arm trial of methoxy polyethylene glycol-epoetin beta in anemia of chronic kidney disease, sponsored by Roche. Started May 2008; status: completed.

02

Drugs

methoxy polyethylene glycol-epoetin beta
03

Conditions

anemia of chronic kidney disease

Beyond the preview

Go deeper on 2008-001747-18.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-001747-18.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call